z-215
Nucleic acidexperimental
Azeloprazole is a drug under investigation for acid-related medical conditions responsive to suppressing the production of stomach acid. It is considered a member of the proton pump inhibitor class of medications. — Wikipedia
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT02463643)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02618629 | Phase 1 | Jan 1, 2016 | Zeria Pharmaceutical |
| NCT02509923 | Phase 1 | Jul 1, 2015 | Zeria Pharmaceutical |
| NCT02463643 | Phase 2 | May 1, 2015 | Zeria Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zeria Pharmaceutical | For profit | 3 | 3 | 2 | 2015 |
1 organizations
Page 1 / 1